211 related articles for article (PubMed ID: 38096960)
1. Oligodendrocyte progenitor cell-specific delivery of lipid nanoparticles loaded with Olig2 synthetically modified messenger RNA for ischemic stroke therapy.
Xu J; Wang R; Luo W; Mao X; Gao H; Feng X; Chen G; Yang Z; Deng W; Nie Y
Acta Biomater; 2024 Jan; 174():297-313. PubMed ID: 38096960
[TBL] [Abstract][Full Text] [Related]
2. Shh and Olig2 sequentially regulate oligodendrocyte differentiation from hiPSCs for the treatment of ischemic stroke.
Xu J; Zhao J; Wang R; Zhang Y; Shen L; Xiao Q; Xie Y; Jiang J; Nie Y; Deng W
Theranostics; 2022; 12(7):3131-3149. PubMed ID: 35547747
[No Abstract] [Full Text] [Related]
3. Ginsenoside Rg1 promotes remyelination and functional recovery in demyelinating disease by enhancing oligodendrocyte precursor cells-mediated myelin repair.
Liu L; Du X; Yang Q; Li M; Ran Q; Liu Q; Yang L; Sun L; Guo Y; Li Y; Chen Y; Zhu X; Li Q
Phytomedicine; 2022 Nov; 106():154309. PubMed ID: 35994846
[TBL] [Abstract][Full Text] [Related]
4. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
Wegener A; Deboux C; Bachelin C; Frah M; Kerninon C; Seilhean D; Weider M; Wegner M; Nait-Oumesmar B
Brain; 2015 Jan; 138(Pt 1):120-35. PubMed ID: 25564492
[TBL] [Abstract][Full Text] [Related]
5. CXCL12 Gene Therapy Ameliorates Ischemia-Induced White Matter Injury in Mouse Brain.
Li Y; Tang G; Liu Y; He X; Huang J; Lin X; Zhang Z; Yang GY; Wang Y
Stem Cells Transl Med; 2015 Oct; 4(10):1122-30. PubMed ID: 26253714
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of BCAS1-positive immature oligodendrocytes after cerebral ischemic stroke and SVD.
Jiang G; Ayaki T; Maki T; Yasuda K; Yoshii D; Kaji S; Takahashi R
Neurosci Lett; 2023 Aug; 812():137405. PubMed ID: 37479175
[TBL] [Abstract][Full Text] [Related]
7. c-Abl-induced Olig2 phosphorylation regulates the proliferation of oligodendrocyte precursor cells.
Zhang J; Sun JG; Xing X; Wu R; Zhou L; Zhang Y; Yuan F; Wang S; Yuan Z
Glia; 2022 Jun; 70(6):1084-1099. PubMed ID: 35156232
[TBL] [Abstract][Full Text] [Related]
8.
Wang J; Yang L; Jiang M; Zhao C; Liu X; Berry K; Waisman A; Langseth AJ; Novitch BG; Bergles DE; Nishiyama A; Lu QR
J Neurosci; 2022 Nov; 42(45):8542-8555. PubMed ID: 36198499
[TBL] [Abstract][Full Text] [Related]
9. Stage-specific deletion of Olig2 conveys opposing functions on differentiation and maturation of oligodendrocytes.
Mei F; Wang H; Liu S; Niu J; Wang L; He Y; Etxeberria A; Chan JR; Xiao L
J Neurosci; 2013 May; 33(19):8454-62. PubMed ID: 23658182
[TBL] [Abstract][Full Text] [Related]
10. ADAMTS4 Enhances Oligodendrocyte Differentiation and Remyelination by Cleaving NG2 Proteoglycan and Attenuating
Jiang C; Qiu W; Yang Y; Huang H; Dai ZM; Yang A; Tang T; Zhao X; Qiu M
J Neurosci; 2023 Jun; 43(24):4405-4417. PubMed ID: 37188512
[TBL] [Abstract][Full Text] [Related]
11. Dl-3-n-butylphthalide promotes remyelination process in cerebral white matter in rats subjected to ischemic stroke.
Cheng X; Wang H; Liu C; Zhong S; Niu X; Zhang X; Qi R; Zhao S; Zhang X; Qu H; Zhao C
Brain Res; 2019 Aug; 1717():167-175. PubMed ID: 30986406
[TBL] [Abstract][Full Text] [Related]
12. Enhancing oligodendrocyte differentiation by transient transcription activation via DNA nanoparticle-mediated transfection.
Li X; Tzeng SY; Zamboni CG; Koliatsos VE; Ming GL; Green JJ; Mao HQ
Acta Biomater; 2017 May; 54():249-258. PubMed ID: 28344151
[TBL] [Abstract][Full Text] [Related]
13. Statin therapy inhibits remyelination in the central nervous system.
Miron VE; Zehntner SP; Kuhlmann T; Ludwin SK; Owens T; Kennedy TE; Bedell BJ; Antel JP
Am J Pathol; 2009 May; 174(5):1880-90. PubMed ID: 19349355
[TBL] [Abstract][Full Text] [Related]
14. Olig2-Targeted G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Survival in Response to Lysolecithin-Induced Demyelination.
Ou Z; Sun Y; Lin L; You N; Liu X; Li H; Ma Y; Cao L; Han Y; Liu M; Deng Y; Yao L; Lu QR; Chen Y
J Neurosci; 2016 Oct; 36(41):10560-10573. PubMed ID: 27733608
[TBL] [Abstract][Full Text] [Related]
15. Microglial neuropilin-1 promotes oligodendrocyte expansion during development and remyelination by trans-activating platelet-derived growth factor receptor.
Sherafat A; Pfeiffer F; Reiss AM; Wood WM; Nishiyama A
Nat Commun; 2021 Apr; 12(1):2265. PubMed ID: 33859199
[TBL] [Abstract][Full Text] [Related]
16. Gain-of-function of Olig transcription factors enhances oligodendrogenesis and myelination.
Maire CL; Wegener A; Kerninon C; Nait Oumesmar B
Stem Cells; 2010 Sep; 28(9):1611-22. PubMed ID: 20672298
[TBL] [Abstract][Full Text] [Related]
17. Prolonged myelin deficits contribute to neuron loss and functional impairments after ischaemic stroke.
Cheng YJ; Wang F; Feng J; Yu B; Wang B; Gao Q; Wang TY; Hu B; Gao X; Chen JF; Chen YJ; Lv SQ; Feng H; Xiao L; Mei F
Brain; 2024 Apr; 147(4):1294-1311. PubMed ID: 38289861
[TBL] [Abstract][Full Text] [Related]
18. Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
Mei F; Mayoral SR; Nobuta H; Wang F; Desponts C; Lorrain DS; Xiao L; Green AJ; Rowitch D; Whistler J; Chan JR
J Neurosci; 2016 Jul; 36(30):7925-35. PubMed ID: 27466337
[TBL] [Abstract][Full Text] [Related]
19. Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression.
Plemel JR; Manesh SB; Sparling JS; Tetzlaff W
Glia; 2013 Sep; 61(9):1471-87. PubMed ID: 23839973
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic Receptor M
Welliver RR; Polanco JJ; Seidman RA; Sinha AK; O'Bara MA; Khaku ZM; Santiago González DA; Nishiyama A; Wess J; Feltri ML; Paez PM; Sim FJ
J Neurosci; 2018 Aug; 38(31):6921-6932. PubMed ID: 29959237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
